Table 3. Risk factors for serious infections.
Incident rate ratio (IRR) obtained from univariable and multivariable Poisson regression.
| Variables | Univariable IRR (95%CI) | P value | Adjusted IRR (95% CI) | P value |
|---|---|---|---|---|
| Age (per 10 yr) | 1.49 (1.24 to 1.80) | <0.001 | 1.46 (1.19 to 1.78) | <0.001 |
| Male | 0.78 (0.46 to 1.32) | 0.34 | 0.83 (.50 to 1.42) | 0.51 |
| MPO | 1.76 (1.03 to 3.02) | 0.04 | 1.32 (0.73 to 2.37) | 0.36 |
| Time from diagnosis to rituximab (per yr) | 0.97 (0.92 to 1.03) | 0.30 | 0.97 (0.91 to 1.04) | 0.41 |
| Duration of continuos rituximab before remission (per mo) | 0.79 (0.53 to 1.17) | 0.24 | 0.99 (0.69 to 1.41) | 0.94 |
| PLEX | 0.64 (0.29 to 1.41) | 0.27 | 0.42 (0.19 to 0.96) | 0.04 |
| IgG < 400 mg/dL | 2.40 (1.22 to 4.72) | 0.01 | 2.13 (1.04 to 4.36) | 0.04 |
Abbreviations: CI, confidence interval; Ig, immunoglobulin; mo, month; MPO, myeloperoxidase; PLEX, plasma exchange; yr, year.